DK2405936T3 - Injicerbare biomaterialer - Google Patents

Injicerbare biomaterialer Download PDF

Info

Publication number
DK2405936T3
DK2405936T3 DK10750240T DK10750240T DK2405936T3 DK 2405936 T3 DK2405936 T3 DK 2405936T3 DK 10750240 T DK10750240 T DK 10750240T DK 10750240 T DK10750240 T DK 10750240T DK 2405936 T3 DK2405936 T3 DK 2405936T3
Authority
DK
Denmark
Prior art keywords
injectable biomaterials
biomaterials
injectable
Prior art date
Application number
DK10750240T
Other languages
English (en)
Inventor
Anthony Steven Weiss
Suzanne Marie Mithieux
Original Assignee
Allergan Pharmaceuticals Int Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2009901028A external-priority patent/AU2009901028A0/en
Application filed by Allergan Pharmaceuticals Int Ltd filed Critical Allergan Pharmaceuticals Int Ltd
Application granted granted Critical
Publication of DK2405936T3 publication Critical patent/DK2405936T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/20—Polysaccharides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/06—Flowable or injectable implant compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Transplantation (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK10750240T 2009-03-10 2010-03-10 Injicerbare biomaterialer DK2405936T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2009901028A AU2009901028A0 (en) 2009-03-10 Injectable biomaterials
PCT/AU2010/000275 WO2010102337A1 (en) 2009-03-10 2010-03-10 Injectable biomaterials

Publications (1)

Publication Number Publication Date
DK2405936T3 true DK2405936T3 (da) 2019-11-04

Family

ID=42727703

Family Applications (2)

Application Number Title Priority Date Filing Date
DK19182834.2T DK3566713T3 (da) 2009-03-10 2010-03-10 Injicerbare biomaterialer
DK10750240T DK2405936T3 (da) 2009-03-10 2010-03-10 Injicerbare biomaterialer

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK19182834.2T DK3566713T3 (da) 2009-03-10 2010-03-10 Injicerbare biomaterialer

Country Status (13)

Country Link
US (1) US8974803B2 (da)
EP (4) EP2405936B1 (da)
JP (1) JP5684154B2 (da)
KR (1) KR101708622B1 (da)
CN (1) CN102348464B (da)
AU (1) AU2010223851B2 (da)
BR (1) BRPI1009422B1 (da)
CA (1) CA2787849C (da)
DK (2) DK3566713T3 (da)
ES (3) ES2755902T3 (da)
HU (2) HUE053947T2 (da)
PL (1) PL3566713T3 (da)
WO (1) WO2010102337A1 (da)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0365746A (ja) * 1989-08-04 1991-03-20 Nec Corp 入出力制御装置
JP5684154B2 (ja) 2009-03-10 2015-03-11 ザ・ユニバーシティ・オブ・シドニー 注射用生体材料
JP2012532963A (ja) * 2009-07-10 2012-12-20 ダウ グローバル テクノロジーズ エルエルシー 電気用積層板組成物における使用のためのコア／シェルゴム
BR112014007451A2 (pt) * 2011-09-30 2017-04-04 Univ Sydney síntese in vivo de fibras elásticas
WO2014063194A1 (en) 2012-10-23 2014-05-01 The University Of Sydney Elastic hydrogel
ES2860023T3 (es) 2012-12-10 2021-10-04 Allergan Pharmaceuticals Int Ltd Fabricación de constructos elásticos tridimensionales escalables
KR20230004965A (ko) * 2013-08-13 2023-01-06 앨러간 파마슈티컬스 인터내셔널 리미티드 손상 조직의 재생
ITMI20131927A1 (it) 2013-11-20 2015-05-21 Cosmo Technologies Ltd Emulsions or microemulsions for use in endoscopic mucosal resectioning and/or endoscopic submucosal dissection. emulsioni o microemulsioni per uso nella resezione mucosale endoscopica e/o dissezione submucosale endoscopica
DE102015207843B4 (de) 2015-04-28 2018-06-07 Duesenfeld Gmbh Verfahren zum Behandeln gebrauchter Batterien und Batterie-Verarbeitungsanlage
CA2996427A1 (en) 2015-09-01 2017-03-09 Allergan Pharmaceuticals International Limited Formation of bone
US10899667B2 (en) * 2017-05-26 2021-01-26 Clemson University Covalently cross-linked lignocellulosic composites and applications thereof
CN107376024B (zh) * 2017-06-29 2021-03-16 成都清科生物科技有限公司 一种用于治疗女性压力性尿失禁的注射制剂及注射方法
MX2022002275A (es) * 2019-08-23 2022-06-02 Allergan Pharmaceuticals Int Ltd Tropoelastina para uso en el tratamiento de cicatrices de acne.
BR112022023209A2 (pt) * 2020-05-14 2023-02-07 Allergan Pharmaceuticals Int Ltd Composições compreendendo tropoelastina reticulada ao ácido hialurônico e métodos de uso das mesmas
WO2023178219A1 (en) * 2022-03-16 2023-09-21 Fibrobiologics, Inc. Therapeutic use of fibroblasts for use in wound healing

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU688746B2 (en) 1992-12-22 1998-03-19 University Of Sydney, The Synthetic polynucleotides
US5726040A (en) 1993-11-10 1998-03-10 Ensley; Burt D. Cosmetic compositions including tropoelastin isomorphs
US7001328B1 (en) 1994-11-15 2006-02-21 Kenton W. Gregory Method for using tropoelastin and for producing tropoelastin biomaterials
US6489446B1 (en) 1996-08-07 2002-12-03 Hsc Research And Development Limited Partnership Self-aligning peptides modeled on human elastin and other fibrous proteins
JP2001505539A (ja) 1996-08-07 2001-04-24 プロテイン・スペシャルティーズ，リミテッド エラスチン及び他の線維状タンパク質由来の自己整列ペプチド
AUPO811797A0 (en) 1997-07-18 1997-08-14 University Of Sydney, The Tropoelastin derivatives
AU9313298A (en) 1997-09-04 1999-03-22 Point Biomedical Corporation Injectable tissue reconstruction material
AUPP472398A0 (en) 1998-07-17 1998-08-13 University Of Sydney, The Protease susceptibility II
US7193043B1 (en) 1998-07-17 2007-03-20 Weiss Anthony S Tropoelastin derivatives
CA2383539C (en) 1999-05-28 2007-12-04 Kenton W. Gregory Methods for producing laminated elastin, elastin-based materials and tropoelastin products for repairing and/or replacing tissue
DK1229940T3 (da) 1999-11-15 2014-08-18 Piramal Healthcare Canada Ltd Temperaturstyret og ph-afhængig selvgelerende, vandig biopolymeropløsning
US20050244393A1 (en) * 1999-12-22 2005-11-03 Henogen S.A. Sealant or tissue generating product
US6808707B2 (en) 2000-02-04 2004-10-26 Matrix Design Wound healing compositions and methods using tropoelastin and lysyl oxidase
US7125960B2 (en) 2001-05-30 2006-10-24 Chisso Corporation Crosslinked elastin and process for producing the same
US8038991B1 (en) 2003-04-15 2011-10-18 Abbott Cardiovascular Systems Inc. High-viscosity hyaluronic acid compositions to treat myocardial conditions
US8383158B2 (en) 2003-04-15 2013-02-26 Abbott Cardiovascular Systems Inc. Methods and compositions to treat myocardial conditions
US8226715B2 (en) * 2003-06-30 2012-07-24 Depuy Mitek, Inc. Scaffold for connective tissue repair
US7968085B2 (en) 2004-07-05 2011-06-28 Ascendis Pharma A/S Hydrogel formulations
US8828433B2 (en) 2005-04-19 2014-09-09 Advanced Cardiovascular Systems, Inc. Hydrogel bioscaffoldings and biomedical device coatings
EP1945144A4 (en) 2005-10-19 2012-12-05 Kenton W Gregory PROCESS FOR THE USE AND PRODUCTION OF TROPOELASTIN AND BIOMATERIALS BASED ON TROPOELASTIN
US20070237735A1 (en) * 2006-03-31 2007-10-11 Laboratoires Dermo-Cosmetik Inc. Anti-aging composition, kit and method of use
EP2117620A4 (en) 2006-09-29 2010-12-01 Martin Kean Chong Ng PROTOELASTINE BIOMATERIALS FROM TROOELASTINE
WO2008058323A1 (en) 2006-11-13 2008-05-22 The University Of Sydney Use of tropoelastin for repair or restoration of tissue
US8469961B2 (en) * 2008-03-05 2013-06-25 Neville Alleyne Methods and compositions for minimally invasive capsular augmentation of canine coxofemoral joints
US8940331B2 (en) 2008-11-22 2015-01-27 The Board Of Trustees Of The Leland Stanford Junior University Hydrogels, methods of making hydrogels, methods of using hydrogels, and methods of isolating, trapping, attracting, and/or killing cancer cells
JP5684154B2 (ja) 2009-03-10 2015-03-11 ザ・ユニバーシティ・オブ・シドニー 注射用生体材料
US8658711B2 (en) 2010-09-29 2014-02-25 Rutgers, The State University Of New Jersey Process for the synthesis of methacrylate-derivatized type-1 collagen and derivatives thereof

Also Published As

Publication number Publication date
AU2010223851B2 (en) 2017-03-16
EP2405936A4 (en) 2012-12-19
HUE047235T2 (hu) 2020-04-28
BRPI1009422A2 (pt) 2016-03-01
HUE053947T2 (hu) 2021-08-30
EP2405936B1 (en) 2019-08-21
US8974803B2 (en) 2015-03-10
KR20110127746A (ko) 2011-11-25
CA2787849C (en) 2018-03-06
ES3010268T3 (en) 2025-04-01
DK3566713T3 (da) 2021-04-06
JP5684154B2 (ja) 2015-03-11
EP3881825B1 (en) 2024-12-25
PL3566713T3 (pl) 2021-12-06
EP3881825A1 (en) 2021-09-22
WO2010102337A1 (en) 2010-09-16
ES2871977T3 (es) 2021-11-02
EP2405936A1 (en) 2012-01-18
ES2755902T3 (es) 2020-04-24
JP2012519713A (ja) 2012-08-30
US20120003283A1 (en) 2012-01-05
EP4534115A2 (en) 2025-04-09
CA2787849A1 (en) 2010-09-16
EP3566713B1 (en) 2021-03-03
EP3566713A1 (en) 2019-11-13
CN102348464A (zh) 2012-02-08
EP4534115A3 (en) 2025-06-11
BRPI1009422B1 (pt) 2019-10-01
AU2010223851A1 (en) 2011-09-22
KR101708622B1 (ko) 2017-02-21
CN102348464B (zh) 2016-05-25

Similar Documents

Publication Publication Date Title
DK2405936T3 (da) Injicerbare biomaterialer
EP3865162C0 (en) RINSE SYRINGE ASSEMBLY
BRPI1008774A2 (pt) espiroamida substituída
DK2411442T4 (da) Umættet polyesterresin
DE112010004215A5 (de) Hydrostataktor
EP2469625A4 (en) OMNIBUS BAR
EP2445547A4 (en) CATHETERISM SYSTEM
DK2430035T3 (da) Uracylspipooxetannukleosider
BRPI1008827A2 (pt) deisobutenizador
BRPI1014968A2 (pt) subalargador
DE112010002728A5 (de) Turboinhalator
DE112010004249A5 (de) Spindelaktor
UY33111A (es) Jeringas
DE112009005323A5 (de) Hebelarmprüfmaschine
BRPI1008070A2 (pt) tricianoboratos
BR112012004964A2 (pt) girocóptero
EP2409976A4 (en) GLYCINE TRANSPORTER INHIBITOR
DK2483126T3 (da) Skinnekøretøj
DE112010004865T8 (de) Lamellennassreibkupplung
DK2506968T3 (da) Faujasit-zeolit
DE112010003255A5 (de) Fördergutverteiler
EP2454221A4 (en) cineole
BRPI1010159A2 (pt) bistuti
EP2398476A4 (en) Policosanol nanoparticles
EP2518828A4 (en) Rfid tag